| Literature DB >> 26199841 |
Dmitry Pankratov1, Richard Sundberg2, Javier Sotres3, Dmitry B Suyatin4, Ivan Maximov2, Sergey Shleev5, Lars Montelius4.
Abstract
Here we detail high performance, enzymatic electrodes for oxygen bio-electroreduction, which can be easily and reproducibly fabricated with industry-scale throughput. Planar and nanostructured electrodes were built on biocompatible, flexible polymer sheets, while nanoimprint lithography was used for electrode nanostructuring. To the best of our knowledge, this is one of the first reports concerning the usage of nanoimprint lithography for amperometric bioelectronic devices. The enzyme (Myrothecium verrucaria bilirubin oxidase) was immobilised on planar (control) and artificially nanostructured, gold electrodes by direct physical adsorption. The detailed electrochemical investigation of bioelectrodes was performed and the following parameters were obtained: open circuit voltage of approximately 0.75 V, and maximum bio-electrocatalytic current densities of 18 µA/cm(2) and 58 µA/cm(2) in air-saturated buffers versus 48 µA/cm(2) and 186 µA/cm(2) in oxygen-saturated buffers for planar and nanostructured electrodes, respectively. The half-deactivation times of planar and nanostructured biocathodes were measured to be 2 h and 14 h, respectively. The comparison of standard heterogeneous and bio-electrocatalytic rate constants showed that the improved bio-electrocatalytic performance of the nanostructured biocathodes compared to planar biodevices is due to the increased surface area of the nanostructured electrodes, whereas their improved operational stability is attributed to stabilisation of the enzyme inside nanocavities.Entities:
Keywords: bilirubin oxidase; bio-electrocatalysis; direct electron transfer; nanoimprint lithography; oxygen reduction reaction
Year: 2015 PMID: 26199841 PMCID: PMC4505184 DOI: 10.3762/bjnano.6.142
Source DB: PubMed Journal: Beilstein J Nanotechnol ISSN: 2190-4286 Impact factor: 3.649
Figure 1AFM (a, b) and SEM (c, d) images of a Au electrode (a, c) and a NIL/Au electrode (b, d).
Figure 2CVs of an NIL/Au electrode (1, 1’) and a Au electrode (2, 2’) modified with MvBOx (1, 2) and without enzyme biomodification (1’, 2’). Conditions: O2-saturated PBS, pH 7.4; 20 mV s−1 scan rate; second cycle.
Figure 3Chronoamperometric responses from a BOx/Au electrode (1) and a BOx/NIL/Au electrode (2). Conditions: O2-saturated PBS, pH 7.4; +400 mV potential applied.